BioSpace News Archive

Business

Astellas Oncology Announces 2019 C3 Prize® Finalists

Astellas Pharma US, Inc. announced the finalists for its fourth annual C3 Prize, a challenge that funds the best ideas beyond medicine to improve cancer care for patients, caregivers and their loved ones.

September 30, 2019
·
4 min read
Pharm Country

Actinium Announces Participation at the 2019 Cell & Gene Meeting on the Mesa

Actinium to highlight its Iomab-ACT program for targeted lymphodepletion for CAR-T and other adoptive cell therapies

September 30, 2019
·
5 min read
Biotech Bay

Audentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including New Data From ASPIRO, the Clinical Trial Evaluating AT132 in Patients With X-Linked Myotubular Myopathy (XLMTM)

Oral presentation of ASPIRO results to include additional efficacy and safety data on all patients in dose Cohort 1 and the first treated patients in dose Cohort 2

September 30, 2019
·
7 min read
Pharm Country

UroGen To Present at October 2019 Investor Conference

UroGen Pharma Ltd., a clinical-stage biopharmaceutical company developing treatments to address unmet needs in uro-oncology, announced that it will present at the following conference in October

September 30, 2019
·
1 min read
Business

A2A Pharmaceuticals Appoints New Advisors

A2A Pharmaceuticals Inc., a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents, announced the formation of its advisory board.

September 30, 2019
·
4 min read
BioMidwest

Stericycle Study Finds Administering Insulin Injections in Public, Lack of Disposal Options Creates Unease Among American Diabetic Community

A quarter of Americans feel embarrassed, anxious to administer insulin in public; one in four are concerned about how to properly dispose of their needles/lancets

September 30, 2019
·
5 min read
FDA

U.S. FDA Approves INVOKANA® (canagliflozin) to Treat Diabetic Kidney Disease (DKD) and Reduce the Risk of Hospitalization for Heart Failure in Patients with Type 2 Diabetes (T2D) and DKD

INVOKANA® is the only diabetes medicine indicated to slow the progression of diabetic nephropathy (also known as DKD) and reduce the risk of hospitalization for heart failure in patients with T2D and DKD

September 30, 2019
·
16 min read
Deals

Platelet BioGenesis Receives $56 Million Contract from the Biomedical Advanced Research and Development Authority (BARDA) to Develop Human Stem Cell-Derived Platelets as a Medical Countermeasure to Radiological and Nuclear Exposure

Funding will support clinical development of stem cell-derived platelet technology platform

September 30, 2019
·
3 min read
Business

Ngen Technologies USA Signs MOU With LGE Research Group

Liberated Solutions, Inc. announced that Ngen Technologies USA Corp has entered into a Memorandum of Understanding with LGE Research group to develop commercial applications using Time-Of-Flight 3D sensor modules to include motion recognition and spatial commands for electronic devices such as smart TVs.

September 30, 2019
·
2 min read
Drug Development

RegeneRx Partner Updates on ARISE-3 Clinical Trial

Enrollment on Target for Completion of Phase 3 Dry Eye Trial in Q2 2020

September 30, 2019
·
5 min read